BNP Paribas Financial Markets
BNR

BNP Paribas Financial Markets’s Burning Rock Biotech BNR Stock Holding History

BNP Paribas Financial Markets’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.4K Hold
2,800
– – ﹤0.01% 5204
2026
Q1 		$45.1K Hold
2,800
– – ﹤0.01% 4747
2025
Q4 		$56.4K Buy
2,800
+1,900
+211% +$27.7K ﹤0.01% 4627
2025
Q3 		$7.79K Hold
900
– – ﹤0.01% 5049
2025
Q2 		$2.84K Buy
900
+100
+13% +$310 ﹤0.01% 5017
2025
Q1 		$3.6K Hold
800
– – ﹤0.01% 4906
2024
Q4 		$5.4K Buy
+800
New +$3.69K ﹤0.01% 4926

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
CL
CRCM LP San Francisco, California $152M AUM 26.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets's BNR Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Burning Rock Biotech (BNR) position steady in Q2 2026 at 2,800 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5204.

BNP Paribas Financial Markets first reported a position in BNR in Q4 2024 and has held it in 7 quarters since. The position peaked at $56.4K in Q4 2025. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

  • BNP Paribas Financial Markets held 2,800 shares of Burning Rock Biotech worth $23.4K as of Q2 2026.
  • BNP Paribas Financial Markets left its Burning Rock Biotech share count unchanged in Q2 2026.
  • Burning Rock Biotech made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5204 holding.
  • BNP Paribas Financial Markets first reported a position in Burning Rock Biotech in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Burning Rock Biotech position peaked at $56.4K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.